THEM6 and posterior cortical atrophy: Importantly, PCa patients presenting with high THEM6 expression consistently displayed shortened progression‐free and recurrence‐free survival in both the PRAD TCGA and the MSKCC (Taylor et al, 2010) cohorts, respectively (Fig 6C and D).